Recombinetics Awarded Two NIH Grants to Develop Humanized Swine Models of Alzheimer’s Disease and Neurofibromatosis 2

Recombinetics announces the receipt of two Small Business Innovative Research (SBIR) grant awards from the National Institutes of Health totaling more than $700,000. The first grant from the National Institute on Aging is to develop a genetically accurate swine model of Alzheimer’s disease. The second grant from the National Institute [...]

Recombinetics Awarded Two NIH Grants to Develop Humanized Swine Models of Alzheimer’s Disease and Neurofibromatosis 22016-10-12T17:05:06-05:00

Recombinetics Awarded NIH Grant to Develop a Humanized Swine Model of Alzheimer’s Disease

ST. PAUL, MINNESOTA – Recombinetics, a global biotechnology leader in gene editing of livestock for human therapeutics and food production applications, has been awarded a $358,338 Phase I Small Business Innovative Research (SBIR) grant from the National Institute on Aging, National Institutes of Health (NIH) to create a genetically accurate [...]

Recombinetics Awarded NIH Grant to Develop a Humanized Swine Model of Alzheimer’s Disease2016-10-01T16:25:54-05:00
Go to Top